HealthQuill Health
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030 deadline looms, according to an International Labour Organization report.
Drugs Health Medical

SDG targets in danger as paychecks shrink globally, ILO says

Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.

Read More
The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in Congo — the outbreak's epicentre.
Drugs Health Pharma

First batch of Bavarian Nordic’s mpox vaccines in Congo by Sept. 5 

The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in.

Read More
A second phase of the polio vaccination will start today in war-raved Gaza after 187,000 children under the age of 10 got oral polio vaccine type 2 (nOPV2) in the central region, in the first round, the WHO stated.
Drugs Health Pharma

Aid workers begin second round of polio vaccinations in Gaza, a 3rd on way

A second phase of the polio vaccination will start today in war-raved Gaza after 187,000 children under the age of 10 got oral.

Read More
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a form of major depressive disorder.
Drugs Health Pharma

Abbott starts trial on deep brain stimulation for depressive disorder

Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a.

Read More
Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to 49 nations in Africa.
Drugs Health Pharma

Eli Lilly to license rheumatoid drug-making technology to Egypt’s EVA

Eli Lilly will license manufacturing know-how of its rheumatoid arthritis baricitinib drug, branded as Olumiant, to Egypt’s EVA Pharma to expand its access to.

Read More
Cholera cases rose 13% and deaths by 71% in 2023 compared to a year earlier as a shortage of oral vaccines continues and the global risk is “high,” according to a World Health Organization report.
Drugs Health Pharma

Cholera killed 4,000 people last year, current global risk of disease ‘high’

Cholera cases rose 13% and deaths by 71% in 2023 compared to a year earlier as a shortage of oral vaccines continues and.

Read More
The World Health Organization has come out with its first-ever guidelines for the manufacturing of antibiotics in a bid to stop environmental emissions and the emergence of new drug-resistant bacteria.
Drugs Health Pharma

WHO issues first-ever guidelines on manufacture of antibiotics

The World Health Organization has come out with its first-ever guidelines for the manufacturing of antibiotics in a bid to stop environmental emissions and.

Read More
Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in 27 member states and other nations.
Drugs Health Pharma

EC approves Merck’s bladder cancer combination therapy in adults 

Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in.

Read More
A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may shape heart diseases and aid physicians in early detection and treatment in the long run, a study finds.
Drugs Health Pharma

Simple blood tests can map women’s heart disease risks when done early

A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may.

Read More
The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according to a statement from the regulator.
Drugs Health Pharma

Novavax’s vaccine targeting JN.1 strain of Covid-19 virus gets FDA approval 

The US Food and Drug Administration cleared Novavax’s Covid-19 vaccine, targeting the JN.1 strain, for people 12 years of age and older, according.

Read More